markets · · 247wallst.com

Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million

Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction until you see what that same bet returned over five years.

Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million

Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction until you see what that same bet returned over five years.

  • #LABU